Children Are Essentially Immune Already So Don’t Touch Them With These COVID Vaccines

November 5, 2021 Updated: November 10, 2021

Commentary

Children’s natural defenses against the SARS-CoV-2 virus, which causes COVID-19, have largely spared them, and I ask, why would we seek to bypass these defenses and threaten them?

Why vaccinate our children for this mild and typically non-consequential virus when they bring protective innate immunity towards SARS-VoV-2, other coronaviruses, and other respiratory viruses? Why push to vaccinate our children who may well be immune due to prior exposure (asymptomatic or mild illness) and cross-reactivity/cross-protection from other coronaviruses (common colds)?

Many children are likely COVID-recovered and as such are immune, so why not consider assessing their immune status? Between their young age and robust innate immunity and this possibility of being COVID-recovered, it should be hands-off regarding the vaccine.

Dr. Geert Vanden Bossche writes that children’s innate immunity “normally/ naturally largely protects them and provides a kind of herd immunity in that it dilutes infectious CoV [coronavirus] pressure at the level of the population, whereas mass vaccination turns them into shedders of more infectious variants.”

“Children/ youngsters who get the disease mostly develop mild to moderate disease and as a result continue to contribute to herd immunity by developing broad and long-lived immunity,” he writes.

This is a potentially very serious issue, for the vaccine offers children no opportunity for benefit and only potential for harm. We could end up harming thousands of our children with these vaccines, for which there’s no proper medium- or long-term safety data. Below are several studies that help make the case that children must be considered “already vaccinated” and must not be touched by these vaccines.

Different Immune Response

Yale and Albert Einstein College of Medicine report on Sept. 18, 2020, in the journal Science Translational Medicine indicates that children and adults display different immune system responses to SARS-CoV-2 infection, which helps in understanding why they have far less illness or mortality from COVID-19.

“Since the earliest days of the COVID-19 outbreak, scientists have observed that children infected with the virus tend to fare much better than adults,” a Yale news article said about the study.

Researchers reported that “levels of two immune system molecules—interleukin 17A (IL-17A), which helps mobilize immune system response during early infection, and interferon gamma (INF-g), which combats viral replication—were strongly linked to the age of the patients. The younger the patient, the higher the levels of IL-17A and INF-g, the analysis showed. These two molecules are part of the innate immune system, a more primitive, non-specific type of response activated early after infection.”

Different Physiology

The virus uses the ACE2 receptor to gain entry to the host cell, and the ACE2 receptor has less presence in the lining of the nose in young children (potentially also in upper respiratory airways); this partly explains why children are less likely to be infected in the first place, or spread it to other children or adults, or to get severely ill—the biological molecular apparatus is simply not there in the nasal cavity of children, as reported eloquently by researchers from the Icahn School of Medicine at Mount Sinai, in New York, and Brigham and Women’s Hospital, in Boston.

By bypassing this natural protection and entering the shoulder deltoid muscle, the vaccine, its mRNA and lipid nanoparticle content, and generated spike protein could be released into the blood circulation and could then damage the lining of the blood vessels and cause severe allergic reactions (e.g. Varga et al. 2020 in The Lancet, Nuovo et al. 2021 in the Annals of Diagnostic Pathology, Ogata et al. 2021 in Clinical Infectious Diseases, and Lei et al. 2021 in Circulation Research).

Fewer COVID-19 Deaths Compared to Other Common Causes

Statistician William Briggs looked at the rationale for vaccinating children based on their risk of death from COVID-19. He notes 542 children up to the age of 17 have died (crude rate of 0.00007 per 100; 132 under 1 year old) since January 2020 with a diagnosis of COVID-19 linked to their death, according to CDC data up to Oct. 22. This doesn’t indicate whether, as Johns Hopkins’s Dr. Marty Makary has been clamoring, the death was “causal or incidental.” That said, since January 2020, 1,043 children aged 0–17 have died of pneumonia.

Briggs writes: “There is no good vaccine for pneumonia. But it could be avoided by keeping kids socially distanced from each other—permanently. If one death is ‘too many,’ then you must not allow kids to be within contact of any human being who has a disease that may be passed to them, from which they may acquire pneumonia. They must also not be allowed in any car. In one year, just about 3,091 kids 0-17 died in car crashes (435 from 0-4, 847 from 5-14, and 30% of 6,031 from 15-24). Multiply these 3,000 deaths in cars by about 1.75, since the Covid deaths are over a 21-month period. That makes about 5,250 kids dying in car crashes in the same period—10 times as many as COVID.”

Yearly, around 500 children in the United States die of seasonal influenza, and there has never been a mandated vaccine.

Briggs concludes, “There exists no justification based on any available evidence for mandatory vaccines for kids.”

Different Immune Systems

Dr. Stuart Weisberg, of Columbia University Irving Medical Center, and colleagues (building on 2018 research work by Brahma Kumar and colleagues at Columbia) suggest that the reason children can more easily neutralize the virus is that their T cells are relatively naïve. They argue that since children’s T cells are mostly untrained, they can thus immunologically respond more rapidly and nimbly to novel viruses such as SARS-CoV-2 for an effective robust response.

Research published in the journal Nature Biotechnology in August 2021 deepens our understanding of this natural type biological/molecular protection even further by showing that pre-activated (primed) antiviral innate immunity in the upper airways of children works to control early SARS-CoV-2 infection.

“The airway immune cells of children are primed for virus sensing, resulting in a stronger early innate antiviral response to SARS-CoV-2 infection than in adults,” states a report on the study by Genetic Engineering and Biotechnology News.

When one is vaccinated or gets infected naturally, this drives the formation, tissue distribution, and clonal evolution of B cells, which is key to encoding humoral immune memory. There is research evidence published in May 2021 in the journal Science that blood from children retrieved prior to the COVID-19 pandemic has memory B cells that can bind to SARS-CoV-2, suggestive of the potent role of early childhood exposure to common cold coronaviruses. This is supported by Mateus and colleagues’ October 2020 report in Science on T cell memory to prior coronaviruses that cause the common cold (known as cross-reactivity/cross-protection).

In closing, there’s very little risk and no data or evidence or science to justify any of the COVID-19 vaccinations in children. Can the content of these vaccines cross the blood-brain barrier in children? We don’t know, for it wasn’t studied. Recklessly so. And the Centers for Disease Control and Prevention, National Institutes of Health, and Food and Drug Administration are all going along with this push when there’s no sound medical justification for this.

In my opinion, based on the science and all the data collected across 19 months, under no circumstances should we expose children to the risk of the COVID-19 vaccinations. To consider putting healthy children at risk so as to protect adults is illogical, irrational, perverse, and reckless. There’s no proper safety data.

The focus rather has to be on early treatment and testing (sero-antibody or T-cell testing) to establish who is a credible candidate for these injections if properly ethically informed and consented to, for it’s also harmful to layer inoculation on top of existing COVID-recovered, naturally acquired immunity (as studies are showing).

What does all of this mean? We could end up harming our children. Liability protection should be taken off the table. Government officials and vaccine companies must stand to be at risk too, not only our children. Don’t touch our children unless you’re 100 percent sure that any drug or vaccine is safe. These vaccines have not been shown to be.

They aren’t needed based on the risk to children from COVID-19—near zero! Consider them already vaccinated. Leave them alone.

Views expressed in this article are the opinions of the author and do not necessarily reflect the views of The Epoch Times.

Dr. Alexander holds masters level study from York University Canada, and a masters in epidemiology from the University of Toronto, a masters in evidence-based medicine from the University of Oxford, and a doctorate in evidence-based medicine and research methods from McMaster University in Canada. He has published on COVID-19 early treatment and has other COVID-related scientific publications. He has teaching experience in epidemiology and in the teaching of clinical epidemiology to masters, doctoral, clinical practitioners, and surgeons in evidence-based medicine and research methodology. Dr. Alexander is a former assistant professor at McMaster University in evidence-based medicine and research methodology; a former COVID Pandemic evidence-synthesis adviser to WHO-PAHO Washington, D.C. (2020) and a former senior adviser on COVID pandemic policy in the U.S. Health and Human Services (HHS) in the Trump administration; worked/appointed in 2008 at WHO as a regional specialist/epidemiologist in Europe's Regional office Denmark (nations involved in assigned WHO project were Russia, Turkey, Ukraine, Poland), worked for the government of Canada as an epidemiologist for roughly 12 years, appointed as the Canadian in-field epidemiologist (2002-2004) to South Asia as part of an international CIDA funded, Health Canada executed project on TB/HIV co-infection and multi-drug resistant TB (MDR-TB) control (involving India, Pakistan, Nepal, Sri Lanka, Bangladesh, Bhutan, Maldives, Afghanistan, posted to Kathmandu); employed from 2017 to 2019 at the Infectious Diseases Society of America (IDSA) Virginia, as the evidence synthesis meta-analysis systematic review guideline development lead/trainer. Currently, he works with and technically supports several international COVID-19 research groups out of the USA, Canada, and elsewhere.